Document is current

Any future updates will be listed below

Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis

Crossref DOI link: https://doi.org/10.1186/S12967-015-0644-4

Published: 2015-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark